Clinical use of CG-201 (Acabel), a new spasmolytic, in urology

摘要

CG-201, a new antispasmodic as well as analgesic, was administered to thirty-three patients having pain mainly due to urolithiasis. Twenty-two patients responded well. Six patients complained of thurst, but this side effect disappeared quickly after discontinuing the drug.